Zydus Cadila(Search results - 11)
India NewsAug 21, 2021, 3:47 PM IST
Zydus Cadila to produce 1 crore doses of COVID vaccine by October
The company stated that it would manufacture 3-5 crore pills by December-January, but it will not achieve the government's August pledge of 5 crore doses.
CoronavirusAug 20, 2021, 9:40 PM IST
India gets needle-free Covid-19 vaccine ZyCoV-D, first of its kind for kids above 12 years
ZyCoV-D is the world's first DNA-based vaccine to get the nod in any country.
Top StoriesJul 1, 2021, 9:53 AM IST
Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine
An approval for Zydus’ vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute.
Top StoriesJun 27, 2021, 10:19 AM IST
Zydus Cadila vaccine for 12-18 age group will be available soon: Centre informs Supreme Court
The Central government informed the Supreme Court that Zydus Cadila, which is developing DNA vaccines, has concluded its clinical trial for children between the age group of 12 to 18 years and the shots will be available soon.
Top StoriesMay 27, 2021, 11:37 AM IST
India's Zydus Cadila seeks DCGI nod to undertake human trial for COVID-19 monoclonal antibodies cocktail
India's Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19.
CoronavirusApr 28, 2021, 3:30 PM IST
Maharashtra extends lockdown-like restrictions till May 15
The cabinet also decided to provide free Covid vaccine to all people in the age group of 18 to 44. The Maharashtra government is in talks with Sputnik, Zydus Cadila and Johnson and Johnson for supplying vaccines to the state.
Top StoriesApr 24, 2021, 4:40 PM IST
DCGI approves Zydus Cadila's Virafin for hepatitis drug for Covid-19 treatment
Earlier in the month, the company had sought approval from the DCGI for the additional indication of hepatitis drug Pegylated Interferon Alpha-2b for treating Covid-19.
Top StoriesNov 28, 2020, 2:26 PM IST
PM goes on Covid-19 vaccine trail, review top 3 contenders
Prime Minister Narendra Modi today personally reviewed the vaccine development and manufacturing process at three of the facilities in Ahmedabad, Pune and Hyderabad. The visit was aimed getting a first-hand perspective of the preparations, challenges and roadmap in India’s endeavour to vaccinate its citizens.
IndiaOct 13, 2020, 1:53 PM IST
Coronavirus: India will have more than one COVID-19 vaccine by early next year: Harsh Vardhan
Currently, two indigenously developed vaccine candidates, one by Bharat Biotech in collaboration with ICMR and the other by Zydus Cadila Ltd, are in phase 2 of the human clinical trials.
IndiaAug 13, 2020, 11:33 AM IST
Coronavirus: Zydus Cadila launches India’s cheapest remdesivir version at Rs 2,800 per vial
Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd
IndiaJul 16, 2020, 4:26 PM IST
Coronavirus: Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection in Gujarat
Doxycycline Injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections.